EP3529251
Naftýridínón-afleiður og notkun þeirra við meðhöndlun á hjartsláttartruflunum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
19.10.2017EP published:
5.10.2022EP application number:
17801105.2
EP translation filed:
19.12.2022Grant published:
15.1.2023EPO information:
European Patent Register
Max expiry date:
18.10.2037Expiry date:
18.10.2023
Title in English:
NAPHTHYRIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ARRHYTHMIALanguage of the patent:
English
Timeline
Today
19.10.2017EP application
5.10.2022EP Publication
19.12.2022Translation submitted
15.1.2023Registration published
18.10.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BARBE, GuillaumeAddress:
Milton MA 02186, US
Name:
BEBERNITZ, Gregory RaymondAddress:
Tupper Lake NY 12986, US
Name:
GENG, SicongAddress:
Pudong Shanghai 201203, CN
Name:
GULGEZE EFTHYMIOU, Hatice BelginAddress:
Cambridge MA 02139, US
Name:
LIAO, LvAddress:
Pudong Shanghai 201203, CN
Name:
MA, FupengAddress:
Cambridge MA 02139, US
Name:
MO, RuoweiAddress:
Cambridge MA 02139, US
Name:
PARKER, David ThomasAddress:
Windham NH 03087, US
Name:
PENG, YunshanAddress:
Cambridge MA 02139, US
Name:
PEUKERT, StefanAddress:
Cambridge MA 02139, US
Name:
YAMADA, KenAddress:
Cambridge MA 02139, US
Name:
YASOSHIMA, KayoAddress:
Cambridge MA 02139, US
Name:
SMITH, NicholaAddress:
Cambridge, MA 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2016/102928Date:
21.10.2016Country:
WO
Number:
201662410930 PDate:
21.10.2016Country:
US
Number:
201662413292 PDate:
26.10.2016Country:
US
Classification
Categories:
C07D 471/04, A61K 31/4375, A61P 9/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 9.12.2022
Expires: 18.10.2023
Payer: Árnason Faktor ehf.